Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Management of patients with cytogenetically normal acute myeloid leukemia who have neither favorable nor unfavorable markers.

Journal of the National Comprehensive Cancer Network : JNCCN - 1 Apr 2014

Walker Alison R, Marcucci Guido

Abstract excerpt

The presence or absence of cytogenetic and molecular abnormalities present at the time of diagnosis of acute myeloid leukemia (AML) not only provides important prognostic information, but also directs decisions regarding postremission therapy. In no other group has molecular analysis been more im...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytogenetics
Share to DNA Mutational Analysis
Share to Gene Expression Profiling

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to FLT3 gene

Share to NPM1 gene

Share to Leukemia, Myeloid, Acute

Share to Mutation

Share to Nucleophosmin

Source

Identifiers

PMID: 24717571
DOI: 10.6004/jnccn.2014.0057

Genes

FLT3
NPM1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-24717571-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Management of patients with cytogenetically normal acute myeloid leukemia who have neither favorable nor unfavorable markers.PMID 24717571Read ↗

Recent progress in AML with recurrent genetic abnormalities.Semantic proximity Read ↗

Prognosis and treatment in acute myeloid leukemia: a comprehensive reviewSemantic proximity Read ↗

Genetic abnormalities in acute myelogenous leukemia with normal cytogenetics.Semantic proximity Read ↗

Molecular prognostic factors in cytogenetically normal acute myeloid leukemia.Semantic proximity Read ↗

Molecular prognostic markers for adult acute myeloid leukemia with normal cytogeneticsSemantic proximity Read ↗

Prognostic implications of genetic aberrations in acute myelogenous leukemia with normal cytogenetics.Semantic proximity Read ↗

Impact of genomics in the clinical management of patients with cytogenetically normal acute myeloid leukemia.Semantic proximity Read ↗

Emerging molecular predictive and prognostic factors in acute myeloid leukemia.Semantic proximity Read ↗

Molecular Genetic Markers in Acute Myeloid LeukemiaSemantic proximity Read ↗

Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: a Cancer and Leukemia Group B Study.Semantic proximity Read ↗

Clinical outcome of de novo acute myeloid leukaemia patients with normal cytogenetics is affected by molecular genetic alterations: a concise review.Semantic proximity Read ↗

Combined molecular and clinical prognostic index for relapse and survival in cytogenetically normal acute myeloid leukemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.